Evaluation of the bioequivalence and pharmacokinetics of two formulations of rizatriptan after single oral administration in healthy volunteers

Arzneimittel-Forschung/Drug Research

Volumn 55, Issue 7, 2005, Pages 355-358

  Chen, Jun ^a   Jiang, Wen Ming ^a   Xie, Yue Ling ^a   Jin, Liang ^a   Mei, Ni ^a   Jiang, Xin Guo ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Antimigraine drug; CAS 144034 80 0; Rizatriptan, bioavailability, bioequivalence, pharmacokinetics

Indexed keywords

RIZATRIPTAN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CAPSULE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; OPEN STUDY; RANDOMIZED CONTROLLED TRIAL; TABLET FORMULATION; VOLUNTEER;

EID: 22544471511     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296872     Document Type: Article

References (9)

1. Teall, J., Tuchman, M., Cutler, N. et al., Rizatriptan (MAX-ALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group. Headache 38, 281 (1998)
2. Tfelt-Hansen, P., Teall, J., Rodriguez, F. et al., Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group. Headache 38, 748 (1998)
3. Vyas, K. P., Halpin, R. A., Geer, L. A. et al., Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humans. Drug Metab. Dispos. 28, 89 (2000)
4. Dooley, M., Faulds, D., Rizatriptan: a review of its efficacy in the management of migraine. Drugs 58, 699 (1999)
5. Loder, E., Brandes, J. L., Silberstein, S. et al., Rizatriptan Protocol 060 Study Group. Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine. Headache 41, 745 (2001)
6. Jamieson, D., Cutrer, F. M., Goldstein, J. et al., Real-world experiences in migraine therapy with rizatriptan. Headache 43, 223 (2003)
7. Chen, J., Jiang, X. G., Jiang, W. M. et al. Liquid chromatographic method for the determination of rizatriptan in human plasma. J. Chromatogr. B Analyt. Biomed. Life Sci. 805, 169 (2004)
8. Goldberg, M. R., Lee, Y., Vyas, K. P. et al., Rizatriptan, a novel 5-HT1B/1D agonist for migraine: single- and multiple-dose tolerability and pharmacokinetics in healthy subjects. J. Clin. Pharmacol. 40, 74 (2000)
9. Lee, Y., Conroy, J. A., Stepanavage, M. E. et al., Pharmacokinetics and tolerability of oral rizatriptan in healthy male and female volunteers. Br. J. Clin. Pharmacol. 47, 373 (1999)